OMERS Administration Corp’s Ironwood Pharmaceuticals IRWD Stock Holding History

OMERS Administration Corp’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$794K	Buy	226,310 +11,200	+5%	+$45.9K	0.01%	699
2025 Q4	$725K	Hold	215,110	–	–	0.01%	591
2025 Q3	$282K	Hold	215,110	–	–	﹤0.01%	900
2025 Q2	$154K	Hold	215,110	–	–	﹤0.01%	799
2025 Q1	$316K	Hold	215,110	–	–	﹤0.01%	848
2024 Q4	$953K	Sell	215,110 -105,300	-33%	-$427K	0.01%	542
2024 Q3	$1.32M	Sell	320,410 -12,800	-4%	-$68.8K	0.01%	473
2024 Q2	$2.17M	Buy	+333,210	New	+$2.36M	0.02%	358
2019 Q3	–	Sell	-58,600	Closed	-$650K	–	447
2019 Q2	$650K	Buy	+58,600	New	+$656K	0.01%	321

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OMERS Administration Corp's IRWD Position: Q1 2026 in Review

OMERS Administration Corp increased its Ironwood Pharmaceuticals (IRWD) stake by 5.2% in Q1 2026, buying an estimated $45.9K and bringing the position to 226,310 shares worth $794K. The position accounts for 0.01% of the portfolio, ranked #699.

OMERS Administration Corp first reported a position in IRWD in Q2 2019 and has held it in 9 quarters since. The position peaked at $2.17M in Q2 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

OMERS Administration Corp held 226,310 shares of Ironwood Pharmaceuticals worth $794K as of Q1 2026.
OMERS Administration Corp bought 11,200 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $45.9K.
Ironwood Pharmaceuticals made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #699 holding.
OMERS Administration Corp first reported a position in Ironwood Pharmaceuticals in Q2 2019 and has held it in 9 quarters since.
OMERS Administration Corp's Ironwood Pharmaceuticals position peaked at $2.17M in Q2 2024.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.